Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Degenerative Joint Disease of Hip clinical trials

2 of 2 indexed Degenerative Joint Disease of Hip trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Degenerative Joint Disease of Hip: 2 US clinical trials tracked, 2 recruiting.

Degenerative Joint Disease of Hip is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is JointMedica, running 1 of these trials.

Enrollment posture brief

Registry condition degenerative-joint-disease-of-hip

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Degenerative Joint Disea (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Degenerative Joint Disease of Hip

Degenerative Joint Disease of Hip lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Degenerative Joint Disease of Hip on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Degenerative Joint Disease of Hip is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

JointMedica 1 trials
Zimmer Biomet 1 trials

Named interventions

Most-linked intervention names on Degenerative Joint Disease of Hip records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Vivacit-E and Longevity (HXLPE) Liners Device
1 trials
Polymotion Hip Resurfacing (PHR) System Device
1 trials

US sites by state

Facility locations filed on Degenerative Joint Disease of Hip trials. A trial with sites in several states counts in each.

Oregon 2 trials
Washington 1 trials
Virginia 1 trials
Utah 1 trials
South Carolina 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Degenerative Joint Disease of Hip page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Degenerative Joint Disease of Hip trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • JointMedica sponsors the most Degenerative Joint Disease of Hip trials on record, review their full trial history before evaluating a specific study. See JointMedica's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Degenerative Joint Disease of Hip condition card totals 2 registered trials; most-linked intervention Vivacit-E and Longevity (HXLPE) Liners; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.